Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1978 Sep;38(3):396–400. doi: 10.1038/bjc.1978.220

Cell-mediated immunity to encephalitogenic factor (MMI test) in women with cervical dysplasia and carcinoma in situ: the effects of serum.

D J Flavell, A Singer, C W Potter
PMCID: PMC2009746  PMID: 81675

Abstract

Lymphocyte sensitivity to encephalitogenic factor (EF) was measured with the macrophage migration inhibition (MMI) test in 60 women with dysplasia or carcinoma in situ of the cervix, in 10 women with invasive cervical carcinoma, and in 20 women with a variety of benign gynaecological conditions. Significant migration inhibition with EF (P less than 0.01) was seen with lymphocytes taken from 7/13 (54%) women with mild and/or moderate dysplasia, from 22/47 (47%) women with severe dysplasia and/or carcinoma in situ, from 6/10 (60%) women with invasive cervical carcinoma and from 3/20 (15%) women with benign gynaecological conditions. Autologous serum was seen to abrogate EF-mediated migration inhibition in 3/4 sensitized women with mild and/or moderate dysplasia, in 5/7 sensitized women with severe dysplasia and/or csrcinoma in situ and in 2/3 sensitized women with invasive cervical carcinoma. Autologous serum from 2 sensitized women with benign gynaecological conditions did not abrogate the response of their lymphocytes to EF.

Full text

PDF
396

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bernard C. C., Lamoureux G. Inhibition by serum of encephalitogenic activity of myelin basic protein: nature of the serum factor responsible. Cell Immunol. 1975 Mar;16(1):182–191. doi: 10.1016/0008-8749(75)90197-5. [DOI] [PubMed] [Google Scholar]
  2. Caspary E. A., Field E. J. Specific lymphocyte sensitization in cancer: is there a common antigen in human malignant neoplasia? Br Med J. 1971 Jun 12;2(5762):613–617. doi: 10.1136/bmj.2.5762.613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Coates A. S., Carnegie P. R. Immunological cross-reactivity between basic proteins of myelin and cancer. I. Lymphocyte transformation studies in immunized guinea-pigs. Clin Exp Immunol. 1975 Oct;22(1):16–21. [PMC free article] [PubMed] [Google Scholar]
  4. Dickinson J. P., Caspary E. A., Field E. J. A common tumour specific antigen. I. Restriction in vivo to malignant neoplastic tissue. Br J Cancer. 1973 Feb;27(2):99–105. doi: 10.1038/bjc.1973.13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dickinson J. P., Caspary E. A. The chemical nature of cancer basic protein. Br J Cancer Suppl. 1973 Aug;1:224–228. [PMC free article] [PubMed] [Google Scholar]
  6. Field E. J., Caspary E. A. Lymphocyte sensitization in advanced malignant disease: a study of serum lymphocyte depressive factor. Br J Cancer. 1972 Jun;26(3):164–173. doi: 10.1038/bjc.1972.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Field E. J., Caspary E. A., Shepherd R. T. Immunodiagnosis of cancer. Br Med J. 1972 Sep 9;3(5827):641–642. doi: 10.1136/bmj.3.5827.641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Flavell D. J., Goepel J., Potter C. W., Carr I. Cellular immunity to encephalitogenic factor as measured by macrophage migration inhibition during tumour induction and growth. Br J Cancer. 1978 May;37(5):818–826. doi: 10.1038/bjc.1978.120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Flavell D. J., Potter C. W. Cellular immunity to encephalitogenic factor in man as measured by the macrophage migration inhibition test: the effects of serum. Br J Cancer. 1978 Jan;37(1):15–22. doi: 10.1038/bjc.1978.2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ford W. H., Caspary E. A., Shenton B. Purification and properties of a lymphocyte inhibition factor from human serum. Clin Exp Immunol. 1973 Oct;15(2):169–179. [PMC free article] [PubMed] [Google Scholar]
  11. Govan A. D., Haines R. M., Langley F. A., Taylor C. W., Woodcock A. S. The histology and cytology of changes in the epithelium of the cervix uteri. J Clin Pathol. 1969 Jul;22(4):383–395. doi: 10.1136/jcp.22.4.383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Harris R., Ukaejiofo E. O. Tissue typing using a routine one-step lymphocyte separation procedure. Br J Haematol. 1970 Feb;18(2):229–235. doi: 10.1111/j.1365-2141.1970.tb01436.x. [DOI] [PubMed] [Google Scholar]
  13. Hughes D., Paty D. W. Lymphocyte sensitivity in cancer. Br Med J. 1971 Jun 26;2(5764):770–770. doi: 10.1136/bmj.2.5764.770. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Koss L. G. Dysplasia. A real concept or a misnomer? Obstet Gynecol. 1978 Mar;51(3):374–379. [PubMed] [Google Scholar]
  15. Light P. A., Preece A. W., Waldron H. A. Studies with the macrophage migration inhibition (MMI) test in patients with malignant disease. Clin Exp Immunol. 1975 Nov;22(2):279–284. [PMC free article] [PubMed] [Google Scholar]
  16. McDermott J. R., Caspary E. A., Dickinson J. P. Antigen cross-reactivity in the macrophage electrophoretic mobility test. A study using cellular affinity chromatography. Clin Exp Immunol. 1974 May;17(1):103–111. [PMC free article] [PubMed] [Google Scholar]
  17. Rees R. C., Potter C. W. Immune response to adenovirus 12-induced tumour antigens, as measured in vitro by the macrophage migration inhibition test. Eur J Cancer. 1973 Jul;9(7):497–502. doi: 10.1016/0014-2964(73)90134-5. [DOI] [PubMed] [Google Scholar]
  18. Shelton J. B., Potter C. W., Carr I. Cellular immunity to myelin basic protein in man and in animal model systems as measured by the macrophage migration inhibition test. Br J Cancer. 1975 May;31(5):528–534. doi: 10.1038/bjc.1975.93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Singer A., Shelton J., Hill S., Potter C. Cellular immunity to human basic myelin protein in women with dysplasia and carcinoma in situ of the cervix. Br J Obstet Gynaecol. 1975 Oct;82(10):820–825. doi: 10.1111/j.1471-0528.1975.tb00580.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES